What began in the Summer of 1956 at Dartmouth College in New Hampshire under John McCarthy has culminated in the beginning of the twenty-twenties. Artificial intelligence is not a new invention of the twenty first century, yet it has garnered an immense amount of public attention since the releases of DALL-E in January 2021 and ChatGPT in November of 2022. Artificial intelligence as an aid for employees and patients is shifting into focus for major players in the Swiss pharmaceutical market. While all kinds of data are generated in substantial quantities and are made accessible to support or optimize business processes, the potential enhancement of the patient value proposition shows promise but remains uncertain. However, enterprises lack the complete blueprints required to develop innovative use cases that enhance the value proposition, as well as the insights needed to determine the efficiency and effectiveness of these use cases.

The goal of this paper is to discover and assess use cases that driven by artificial intelligence for pharmacies in Switzerland in order to solve the problem of shortage of skilled workforce.

The findings indicate promising potential and lead to new possibilities that need to be explored further.